What they found: Cagrilintide 4.5 mg: 10.8 % weight reduction vs 3.0 % placebo (p 40 % of patients achieved 25 % weight reduction , historically unprecedented Safety profile in line with Phase 2 data Why it matters: REDEFINE 1 confirmed CagriSema as the largest body-weight signal reported in the published incretin literature to date
Mechanistic data suggest that environmental pollutants may influence IBD risk and outcomes through microbial dysbiosis and intestinal barrier disruption, ultimately leading to intestinal inflammation
These capsules conveniently and effectively harness the therapeutic potential of thymosin beta-4 without the need for injections
Studies have shown that GHK-Cu can stimulate collagen and glycosaminoglycan synthesis, improve skin remodeling, and support wound healing processes
A company with well-publicized patent expirations priced into its stock, like Bristol Myers Squibb facing the Revlimid cliff in 2023, offers a different investment proposition than a company whose patent exposure is poorly understood
Your provider will determine if Tirzepatide can be safely combined with other diabetes medications based on your specific situation